Guoqing Wu
- Cancer Research top 10%
- MicroRNA in disease regulation 4
- Immunology top 10%
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 4
- interferon and immune responses 2
- Developmental Neuroscience top 10%
- Psychiatry and Mental health top 10%
- Cancer, Stress, Anesthesia, and Immune Response 3
-
- Cancer Immunotherapy and Biomarkers 6
-
- Bladder and Urothelial Cancer Treatments 3
-
- RNA modifications and cancer 3
- Co-authors
- Jian ZhangLiyun XuDongdong ChenYongkui ZhangChangchang LuYanyan HuangZhiying FengShengmei Zhu
- Journals
- Biochemical and Biophysical Research Communications (1 paper)Journal of Controlled Release (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Guoqing Wu
24 papers receiving 693 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 198
- Immunology 254
- Developmental Neuroscience 39
- Psychiatry and Mental health 136
- Oncology 226
Countries citing papers authored by Guoqing Wu
This map shows the geographic impact of Guoqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoqing Wu more than expected).
Fields of papers citing papers by Guoqing Wu
This network shows the impact of papers produced by Guoqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoqing Wu. The network helps show where Guoqing Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Guoqing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2023 | 5 | |
| 4 | 2023 | 22 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 70 | |
| 10 | 2022 | 2 | |
| 11 | 2018 | 66 | |
| 12 | 2017 | 6 | |
| 13 | 2015 | 75 | |
| 14 | 2015 | 172 | |
| 15 | Advanced Lung Cancer Is Associated with Decreased Expression of Perforin, CD95, CD38 by Circulating CD3+CD8+ T Lymphocytes. | 2015 | 9 |
| 16 | 2014 | 87 | |
| 17 | 2014 | 29 | |
| 18 | 2013 | 36 | |
| 19 | 2013 | 51 | |
| 20 | [Study of differential expressed genes in vascular endothelial cell line ECV304 induced by low density lipoprotein]. | 2000 | 1 |
About Guoqing Wu
Guoqing Wu is a scholar working on Immunology, Cancer Research and Developmental Neuroscience, having authored 24 papers that have together received 702 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Immune Cell Function and Interaction (6 papers), MicroRNA in disease regulation (4 papers), Immunotherapy and Immune Responses (4 papers), Bladder and Urothelial Cancer Treatments (3 papers), Cancer, Stress, Anesthesia, and Immune Response (3 papers), RNA modifications and cancer (3 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (198 citations), Immunology (254 citations) and Developmental Neuroscience (39 citations). Guoqing Wu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jian Zhang, Liyun Xu, Dongdong Chen, Yongkui Zhang, Changchang Lu, Yanyan Huang, Zhiying Feng, Shengmei Zhu, Wei Yu and Xiaoguang Liu. Their work appears in journals such as Biochemical and Biophysical Research Communications, Journal of Controlled Release and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.